Algal biotechnology: facts, fiction and future prospectsAlgal biotechnology: facts, fiction and...
Transcript of Algal biotechnology: facts, fiction and future prospectsAlgal biotechnology: facts, fiction and...
-
Algal biotechnology: facts, fiction and future prospects
John G Day
Coordination Centre:Scottish Association for Marine Science, Oban, Scotland
T: +44 (0)1631 559000F: +44 (0)1631 559001E: [email protected]: www.biomara.org
Project supported by the INTERREG IVA Programme managed by SEUPB
-
Why bother with Algae?
• Algae are debatably the most diverse group of organisms on earth
-
Why bother with Algae?• Algae are responsible for the oxygen in every second breath you take• They form the basis of the food chain for approx 70% of the worlds biomass• Without algae the world dies!
-
If algae are such a big deal, how come we never hear about them?
-
Algal exploitation: Historical perspective
Seaweed being
harvested in 19th century for use as a fertiliser
-
Kelp Burning: a biotechnology process from the 18th & 19th centuries to produce soda, potash &
iodine
.
-
Phyco‐colloidsAgar7,500 tonnes of agar with a wholesale value of US$250 million.
Alginates>$120M excluding China
Carrageenan> 50,000 tonnes in 2007/8 with a value of over US$600 million (excluding China)
-
Alginate: A Natural Chemicalwith Diverse Uses
• Alginates are jelly‐like carbohydrates used for water retention, gelling, emulsifying and stabilising.
• Used in food, drink, cosmetics, medical and chemical industries
• Currently there are some 250 applications
-
ISP Alginates Plant, Girvan
Girvan one of the world’s largest alginate plant
-
More than 20 species are used in everyday cookery in Japan, six of them since the 8th century.
Seaweed accounts for some 10% of the Japanese diet
Most important food species in Japan are Nori (Porphyraspecies), Kombu (Laminaria species), and Wakame (Undaria pinnatifida)
Nori a $1 billion Industry
-
Seaweed Products
http://www.tavay-organics.fsnet.co.uk/soil_improver.html
-
What about Microalgae?
-
Historical use of algae:
Food-supplement in central Africa & Central America
Spirullina /Arthrospira
-
•Chaetoceros calcitrans
•Isochrysis sp. (Tahitian)
•Nannochloris atomus
•Pavlova lutheri CCAP
•Rhinomonas reticulata var. reticulata
•Skeletonema costatum
•Tetraselmis chui
Thalassiosira pseudonana
Aquaculture a multi-billion $ Industry
-
Current uses of microalgae“Witchcraft”
Dietary supplements
Health foods
Neutraceuticals
Pigments & specialist chemicals
-
Microalgae & cyanobacteriaCOMMERCIALLY exploited and
grown at large scale
Chlorella spp
Aphanizomenon flos aquae
Arthrospira/ Spirullina spp
Dunaliella salina
Haematococcus pluvialis
Cryptothecodinium cohenii
-
Production systems: Open
-
Production systems: closed
-
Future Prospects – Industrial needs• Pharmaceutical
• New bio‐active molecules with novel modes of action / chemical structure (new chemical scaffolds).
• Need for new drugs (emerging diseases / drug resistance)
• Nutraceuticals• Functional foods (Fatty acids ‐micro algae) – heart
health, obesity control, immuno health.• Probiotics (animal and human)• Anti‐oxidants
• Industrial• Biofuels• New sources of enzymes – biotransformation of
chemicals• .New Cosmetics (cosmoceuticals)
-
Future product areas
• Biofuels• Foods• Bioactives/ Pharmaceuticals
• Novel enzymes• Specialist chemicals• Green fertilizers• Green insecticides • Bioremediation
-
Bioactives: pharmaceuticals
•They are, as yet, a largely unexploited biotechnological “treasure store”
-
ConstraintsTechnological constraints• Production systems engineering problems• Downstream processing/ product
extraction/purification/formulation• Production strain productivity• Production strain stability
Can you protect your IP?• Yes… Can you afford to defend challenges to your patents?• No… Can you protect your know-how by some other method?
Do not forget the Convention on Biological Diversity (CBD) & the UN Convention on the Law of the Sea (UNCLOS)!• Are you a BioPirate?
-
Future prospectsAlgal production- parallels with penicillin production:
March 14, 1942 the first patient was treated for streptococcal septicaemia with U.S.-made penicillin used half of the total supply produced.
By Spring of 1944 the USA to produce 2.3 million doses in time for the invasion of Normandy.
$1000/Kg $100/Kg $10/Kg $1/Kg c/Kg
-
Reality check:Market driven or technology driven?
Production economics…
Investment…
-
Conclusions:
There must be a market need.
Production must be reliable AND COST EFFECTIVE.
The technology must be robust and reliable.
Ideally the technology should be a platform for a suite of products.
The technology should be protectable.
Get it right and……. $
Algal biotechnology: facts, fiction and future prospects Algal exploitation: �Historical perspective.Alginate: A Natural Chemical�with Diverse UsesISP Alginates Plant, GirvanFuture Prospects – Industrial needsFuture product areasBioactives: pharmaceuticalsConstraintsFuture prospectsAlgal biotechnology: facts, fiction and future prospects Algal exploitation: �Historical perspective.Alginate: A Natural Chemical�with Diverse UsesISP Alginates Plant, GirvanFuture Prospects – Industrial needsFuture product areasBioactives: pharmaceuticalsConstraintsFuture prospects